Publications by experts at Camargo Pharmaceutical Services

Below is an introductory listing of the many contributions that members of Camargo have made to peer-reviewed professional literature.

Information about some of their scientific presentations, abstracts and posters appears under Presentations.

• Marx P, Schade G, Maki KC, Wilbourn S, S Blank, M.D., DL. Moyer, M.D., R Nett, M.D., R Stevens. Low-Dose (0.3 mg) Synthetic Conjugated Estrogens, A (Cenestin®) is Effective for Managing Atrophic Vaginitis in Postmenopausal Women.  Maturitas, Submitted August, 2002.
• Lane NE, Kumer JL, Majumdar S, Khan M, Lotz J, Stevens RE, Klein R, Phelps KV. The Effects of Synthetic Conjugated Estrogens, A (Cenestin®) on Trabecular Bone Structure and Strength in the Ovariectomized Rat Model.  Osteoporosis International, 2002, Vol. 13, No.10, Pages 816-823.
• RE Stevens, Vaginal Atrophy Returns 4 Weeks after Stopping ERT. Obstetrics & Gynecology News, Ed. Betsy Bates, Los Angles Bureau, July 1, 2002.
• P Garnero, RE Stevens, SA Ayres, KV Phelps.  Short-Term Effects Of A New Synthetic Conjugated Estrogens On Biochemical Markers Of Bone Turnover In Early Postmenopausal Women.  Journal of Clinical Pharmacology, 2002; 42 (3): Pages 290-295.
• RE Stevens, P Roy, KV Phelps.  Evaluation of Single and Multiple Dose Pharmacokinetics of Synthetic Conjugated Estrogens, A (Cenestin®) Tablets:  A Slow-Release Estrogen Replacement Product. Journal of Clinical Pharmacology, 2002; 42 (3): Pages 332-341.
• RE Stevens, J Konsil, SS Verrill, P Roy, P Desai, DH Upmalis, FL Cone.  Bioavailability Study of a 1200 mg Miconazole Nitrate Vaginal Ovule in Healthy Female Adults.  Journal of Clinical Pharmacology, 2002; 42 (2): Pages 1-9.
• Baer JT and Ayres SA. Estrogen levels and lipid peroxidation following exercise. Preventive Cardiology, 2001, Vol. 4, Pages 85-87.
• JA Simon, RE Stevens, SA Ayres, KV Phelps.  Perimenopausal Women in Estrogen Vasomotor Trials:  Contribution to Placebo Effect and Efficacy Outcome.  Climacteric, March 2001, Vol. 4, Number 1, Pages 19-27.
• Stevens RE, Ayres SA, Klein R and Phelps KV. Effect of estrogen replacement therapy on climacteric symptoms in African-American and Caucasian menopausal women: influence of body mass index. Obstetrics & Gynecology, 2001, Vol. 97, No. 4 Suppl 1, Page S24.
• Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.  Efficacy of synthetic conjugated estrogens in the treatment of vasomotor symptoms. Menopause Digest, 2001, Vol. 13, No. 5, Pages 16-18.
• RE Stevens, KH Hanford, S Wason, SL Cusack, KV Phelps.  A Unique 12 Week Clinical Trial Determining the Efficacy of Synthetic Conjugated Estrogens in the Treatment of Vasomotor Symptoms in Menopausal Women.  International Journal of Fertility, 2000, Vol. 45, No. 4, Pages 264-272.
• RE Stevens, T Limsakun, G Evans, DH Mason.  Controlled, Steady-State, Pharmacokinetic Evaluation of Two Extended Release Carbamazepine Formulations (CarbatrolÒ and Tegretol-XRÒ).  Journal of Pharmaceutical Sciences, 1998, Vol. 87, No. 12, Pages 1531-1534.
• Ayres SA, Abplanalp W, Liu JH, and Subbiah MTR. Mechanisms involved in the protective effect of estradiol-17b on lipoprotein peroxidation and DNA damage. American Journal of Physiology, 1998, Vol. 274, Pages 1002-1008.
• Ayres SA, Baer J and Subbiah MTR. Exercise-induced increase in lipid peroxidation parameters in amenorrheic female athletes. Fertility and Sterility, 1998, Vol. 69, Pages 73-77.
• Ayres SA, Tang M and Subbiah MTR. Estradiol-17b as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. Journal of Laboratory & Clinical Medicine, 1996, Vol. 128, No. 4, Pages 367-375.
• Tang M, Abplanalp W, Ayres SA and Subbiah MTR. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism., 1996, Vol. 45, No. 4, Pages 411-414.
• Klecker, RW., Jamis-Dow, CA., Egorin, MJ., Erkmen, K., Parker, RJ., Stevens, RE., Collins, JM.  Effect of Cimetidine, Probenecid, and Ketoconazole on the Distribution, Biliary Secretion, and Metabolism of [H3]Taxol in the Sprague-Dawley Rat. Drug Metabolism and Disposition, 1994, Vol. 22, No. 2, Pages 254-258.